Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Zarir Udwadia and Monika Tandon.
Zarir Udwadia
Connection Strength
1.843
Monika Tandon
  1. Response to the comments received on article "Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial" by Udwadia et al. Int J Infect Dis. 2021 04; 105:686-687.
    View in: PubMed
    Score: 0.930
  2. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial. Int J Infect Dis. 2021 Feb; 103:62-71.
    View in: PubMed
    Score: 0.914
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.